03 May 2022

Mathys & Squire appoints biotech Partner Iain Armstrong

We are pleased to announce the appointment of a biotech Partner Iain Armstrong.

Iain has over 20 years’ experience advising clients in the life sciences field, providing practical and pragmatic advice through the entire patent process. He has a particular interest in stem cell technologies, wound healing, and cell therapies (such as CARs), reflecting his background in cell biology. Iain also works extensively on inventions relating to antibody therapeutics, diagnostics, and personalised medicines. 

The firm’s new Partner joins Mathys & Squire from IP law firm HGF, where he worked with multiple universities, research organisations and startups across the world. Iain’s practice concentrates primarily on the therapeutic applications of biological inventions, with a particular focus on technologies relating to cell biology.

Martin MacLean, Partner and head of the life sciences team at Mathys & Squire, comments: “I’m absolutely delighted to welcome Iain onboard; it’s a coup for Mathys & Squire to attract a senior attorney of Iain’s calibre. His energy and enthusiasm speak volumes and his track record is exemplary. Iain’s appointment is a major step in furthering Mathys & Squire’s strategic development in the life and medical sciences sectors. His extensive biotech knowledge and legal experience will prove a significant long-term asset to the firm.”

This release has been published in Pro-Manchester, The Patent Lawyer and Juve Patent.